Quarterly report pursuant to Section 13 or 15(d)

Clinical Trial and Sponsored Research Agreements (Tables)

v3.22.2
Clinical Trial and Sponsored Research Agreements (Tables)
6 Months Ended
Jun. 30, 2022
Sponsored Research and Clinical Trial Agreements [Member]  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]  
Schedule of Clinical Trial and Sponsored Research Agreements

For the three and six months ended June 30, 2022 and 2021, the Company recorded the following expense in research and development for sponsored research and clinical trial agreements in the Unaudited Statements of Operations pursuant to the terms of this agreement:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the three months ended June 30, 

​

For the six months ended June 30, 

($ in thousands)

    

2022

    

2021

    

2022

    

2021

City of Hope National Medical Center

​

$

—

​

$

—

​

$

—

​

$

—

CD123

​

​

52

​

​

21

​

​

103

​

​

226

IL13Rα2

​

​

234

​

​

279

​

​

462

​

​

793

CS1

​

​

50

​

​

197

​

​

100

​

​

372

HER2

​

​

271

​

​

31

​

​

542

​

​

154

PSCA

​

​

28

​

​

(4)

​

​

50

​

​

46

Fred Hutchinson Cancer Research Center - CD20

​

​

358

​

​

327

​

​

846

​

​

998

St. Jude Children's Research Hospital - XSCID

​

​

94

​

​

176

​

​

218

​

​

280

LUMC - RAG1 SCID

​

​

138

​

​

—

​

​

265

​

​

—

Mayo Clinic

​

​

231

​

​

233

​

​

462

​

​

233

Total

​

$

1,456

​

$

1,260

​

$

3,048

​

$

3,102